主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
日本語
English
Русский
中文
Español
Português
Deutsch
한국어
Français
Italiano
Türkçe
MLTX
#2018
MoonLake Immunotherapeutics Class A Ordinary Shares
17.510
0
-0.68%
版块:
基础:
利润货币:
日范围
年范围
日变化
-0.68%
每月变动
+7.49%
6个月变化
+83.16%
年变化
+83.16%
前一天收盘价
17.630
0
Open
17.510
0
Bid
Ask
Low
17.510
0
High
17.510
0
交易量
76
市场
股票
医疗保健
MLTX
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
63.06 M
63.28 M
63.47 M
63.5 M
63.7 M
71.73 M
—
Valuation ratios
Enterprise value
9.3 B
10.22 B
7.26 B
8.79 B
1.03 B
2.5 B
19.59 B
Price to earnings ratio
-40.02
-28.65
-16.99
-16.98
-2.16
-3.73
-39.86
Price to sales ratio
7 512.11
-80.7 K
-12.32 K
13.78 K
889.04
1 418.42
3 765.23
Price to cash flow ratio
-15.87
-29.2
-7.78
-14.57
-9.32
4.33
-27.34
Price to book ratio
1.45
7.62
1.32
1.75
0.3
2.79
6.17
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.07
-0.4
0.08
0.12
0.17
0.15
0.51
Return on equity %
-0.07
-0.42
0.1
0.15
0.24
0.21
0.7
Return on invested capital %
-774.68
-4 018
753.51
875.86
762.97
583.45
2 975.79
Gross margin %
100
100
100
100
100
100
400
Operating margin %
161.19 K
140.68 K
135.67 K
16.06 K
26.75 K
-80.51 K
97.97 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
132.32 K
114.32 K
114.13 K
14.61 K
26.12 K
-77.07 K
77.78 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
25.51
21.11
21.11
16.65
8.5
9.27
55.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
-0
-0
0
0
0
-0
0
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
0.14
0.16
0.18
0.17
0.65
Long term debt to total equity ratio
—
—
0.18
0.21
0.26
0.24
0.89
Per share metrics
Operating cash flow per share
-1.76
-2.94
0.6
0.86
0.7
0.91
3.08
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
7.85
7.13
7.59
6.72
6
6.11
26.43
Net current asset value per share
8.15
7.54
8.01
7.2
6.49
6.54
28.23
Tangible book value per share
7.77
7.11
6.44
5.59
4.56
4.72
21.32
Working capital per share
7.83
7.19
7.63
6.77
5.73
5.84
25.95
Book value per share
7.76
7.11
6.44
5.59
4.56
4.72
21.32
新闻
MoonLake: Downgrade To Buy As Sonelokimab Still Has A BLA Shot On Goal (NASDAQ:MLTX)
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day - Slideshow (NASDAQ:MLTX) 2026-02-23
MoonLake Immunotherapeutics (MLTX) Analyst/Investor Day Transcript
MoonLake株、軸性脊椎関節炎試験の良好なデータで急騰
MoonLake stock surges on positive axSpA trial data
InvestingProの適正価値判定後、MoonLake株が63%急騰
MoonLake stock surges 63% after InvestingPro Fair Value call
MoonLake、軸性脊椎関節炎のフェーズ2で良好なデータを報告
MoonLake reports positive phase 2 axial spondyloarthritis data
ImageneBio appoints Dr. Porter-Brown as Chief Medical Officer
BTIGがデータ発表を前にムーンレイク・イムノセラピューティクス株の買い推奨を再確認
BTIG reiterates Buy rating on Moonlake Immunotherapeutics stock ahead of data